OCX 13G

Company

Insight Molecular Diagnostics Inc.

Filed

February 14, 2023

Accession Number

0001535264-23-000015

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →